Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jung Hyun Kwon"'
Autor:
Hyung Joon Yim, Sae Hwan Lee, Jung Hyun Kwon, Jun Yong Park, Dong Hyun Sinn, Eileen L. Yoon, Ji Hoon Kim, Hyun Woong Lee, Hana Park, Jeong Hoon Lee
Publikováno v:
Clinical and Molecular Hepatology
Clinical and Molecular Hepatology, Vol 26, Iss 4, Pp 411-429 (2020)
Clinical and Molecular Hepatology, Vol 26, Iss 4, Pp 411-429 (2020)
Clinical practice guidelines are important for guiding the management of specific diseases by medical practitioners, trainees, and nurses. In some cases, the guidelines are utilized as a reference for health policymakers in controlling diseases with
Autor:
Jeong Won Jang, Si Hyun Bae, Myeong Jun Song, Seung Kew Yoon, Seok Hwan Kim, Sang Wook Choi, Nam Ik Han, Pil Soo Sung, Do Seon Song, Sun Hong Yoo, Se Hyun Cho, Jin Mo Yang, Sung Won Lee, Soon Woo Nam, Hae Lim Lee, Joon-Yeol Han, Jung Hyun Kwon, Jong Young Choi, Hee Yeon Kim, Chan Ran You, Chang Wook Kim, U Im Chang
Publikováno v:
Journal of Medical Virology. 91:1104-1111
Background A real-life study is essential outside clinical trials. The aim is to evaluate the clinical outcomes of direct acting agents (DAA) for patients with chronic hepatitis C (CHC) in real practice. Methods We analyzed 590 consecutively enrolled
Autor:
Seung Kew Yoon, Sa-Jin Kim, Si Hyun Bae, Kwang Il Seo, Juyoung Lee, Pil Soo Sung, Hyun Seung Lee, Hye Ji Kim, Jong Hyun Kim, Se Hyun Jo, Jong Young Choi, Young Moo Lee, Bo Hyun Jang, Chung-Hwa Park, Chang Wook Kim, U Im Chang, Hae Lim Lee, Jeong Won Jang, Hee Yeon Kim, In-Yang Park, Fisseha Tekle, Jung Hyun Kwon
Publikováno v:
Clinical and Molecular Hepatology, Vol 24, Iss 4, Pp 374-383 (2018)
Clinical and Molecular Hepatology
Clinical and Molecular Hepatology
Background/Aims There have been numerous efforts to reduce mother-to-child transmission (MTCT) of hepatitis B virus (HBV) with antiviral agents during pregnancy. However, there are limited data regarding the outcomes of pregnant women after delivery.
Autor:
Pil Soo Sung, Sung Won Lee, Seung Kew Yoon, Hyunyu Choi, Hein Yu, Dong Wook Jekarl, Seungok Lee, Yonggoo Kim, Jung Hyun Kwon, Myungshin Kim
Publikováno v:
Annals of Laboratory Medicine
BACKGROUND Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA-M2BP) is a protein with altered glycosylation that reacts with lectin, and was recently identified as a useful non-invasive biomarker for the diagnosis of liver fibrosis in
Autor:
Chan Ran You, Seung Kew Yoon, Myeong Jun Song, Chang Wook Kim, Si Hyun Bae, Do Seon Song, Hee Yeon Kim, Sang Wook Choi, Jeong Won Jang, Sung Won Lee, Jong Young Choi, Chung-Hwa Park, Jung Hyun Kwon
Publikováno v:
European Journal of Gastroenterology & Hepatology. 28:1179-1187
Background and aims Entecavir (ETV) is a potent nucleoside analogue with high genetic barrier to resistance. In this study, real-life clinical experiences in the long-term use of ETV and the durability of its off-treatment effectiveness were analyzed
Autor:
Si Hyun Bae, Soon Woo Nam, Bo Hyun Jang, Jung Hyun Kwon, Won Lee, Jong Young Choi, Hee Chul Nam, Pil Soo Sung, Seung Kew Yoon, Sun Hong Yoo, Jeong Won Jang
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 71(3)
Background The effect of prophylactic antiviral therapy (AVT) on survival of patients with hepatitis B virus (HBV)–related hepatocellular carcinoma (HCC) remains unknown. This study aimed to determine whether prophylactic AVT could improve long-ter
Autor:
Kwang Hyub Han, Si Hyun Bae, Hye Won Lee, Dong Joon Kim, Jin-Woo Lee, Jae Youn Cheong, Byung Ik Kim, Yeon Seok Seo, Sang Hoon Ahn, Ja Kyung Kim, Jun Yong Park, Tae Yeob Kim, Jung Hyun Kwon, Byoung Kuk Jang, Hyung Joon Yim, Sang Gyune Kim, Moon Young Kim, Sung Min Myoung, Won Young Tak, Soung Won Jeong, Ki Tae Yoon, So Young Kwon
Publikováno v:
Clinical Gastroenterology and Hepatology. 17:2811-2813.e1
Hepatitis B virus (HBV) suppression with nucleot(s)ide analogue therapy reduces the risk of hepatic decompensation and hepatocellular carcinoma (HCC) in patients with advanced liver disease.1 In the present era of potent antiviral therapies, the prog
Publikováno v:
Pediatric Infection & Vaccine. 26:60
Autor:
Tae-Hun Kim, Oh Sang Kwon, Sang Gyune Kim, Young Seok Kim, Jeong Won Jang, Young Kul Jung, Jung Hyun Kwon
Publikováno v:
Gut and Liver. 7:197-205
Background/Aims: Genotype C is the principal type of hepatitis B virus (HBV) in Koreans and is associated with poor prognosis for peginterferon α-2a therapy. The efficacy of and compliance to peginterferon α-2a therapy were investigated in Koreans
Autor:
Seung Kew Yoon, Si Hyun Bae, Chung-Hwa Park, Jong Young Choi, Sun Hong Yoo, Jeong Won Jang, Jung Hyun Kwon
Publikováno v:
Journal of Medical Virology. 85:34-42
Regarding the limited evidence for determining the optimal duration of antiviral treatment for hepatitis B, the long-term outcome of patients with favorable responses to over 5 years of lamivudine monotherapy was investigated. Two hundred seventy-one